Get notified of page updates

Search Results: (19 results)

New Search

PRINTER FRIENDLY PAGE 331 through 349 of 349

Safety and Efficacy of Olaparib Alone Or in Combination with Medication Targeting DNA Damaging Repair for Metastatic Triple Negative Breast Cancer

The purpose of this study is to learn the safety and effectiveness of the PARP inhibitor, olaparib as a single drug therapy compared with olaparib in combination with the new agent AZD6738 in patients with metastatic Triple-Negative Breast Cancer (TNBC). NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT03330847

Olive Oil for High Risk Breast Cancer Prevention

This study will evaluate the effect of hydroxytyrosol, a component of olive oil, on breast density in women who are at high risk for developing breast cancer. UPDATE: THIS STUDY IS NO LONGER ENROLLING PATIENTS.

Clinicaltrials.gov identifier: NCT02068092

Auricular Point Acupressure to Self-Manage Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors

Severe joint pain and muscle stiffness are common side effects of taking Aromatase Inhibitors. Aromatase inhibitor musculoskeletal symptoms have a negative effect on a woman's physical function and quality of life. Auricular point acupressure uses stimulation applied to points on the ear without using needles. This study will look at and test auricular (ear) point acupressure to manage aromatase-inhibitor-caused joint pain and muscle stiffness in breast cancer survivors.

Note: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03697200

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)

This study will look at how safe, effective and tolerable the oral PARP inhibitor Rucaparib is when used in combination with other anticancer agents in patients with advanced solid tumors, including triple-negative breast cancer, ovarian cancer or urothelial cancer. Note: This study has completed enrollment.

Clinicaltrials.gov identifier: NCT03992131

Study of Safety and Effectiveness of Motiva® Breast Implants

Note: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03579901

The Women Choosing Surgical Prevention (WISP) Trial

The WISP Study is closed to enrollment. Stay tuned for updates from FORCE on study results or new studies for ovarian cancer prevention.

Clinicaltrials.gov identifier: NCT02760849

A Study to Evaluate Rucaparib in Patients with Solid Tumors and with Deleterious Mutations in HRR Genes (LODESTAR)

The LODESTAR study is evaluating the response of the PARP inhibitor rucaparib in people with advanced solid tumors (including breast, ovarian, pancreatic, prostate and other cancers) who have an inherited mutation or an acquired mutation in any of the following genes: BRCA1, BRCA2, PALB2, RAD51C, RAD51D, BARD1, BRIP1, FANCA, NBN, RAD51 or RAD51B. NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT04171700

A Non-Randomized Phase II Research Study of M6620 (VX-970) in Selected Solid Tumors to Inhibit the ATR Enzyme.

This clinical trial is studying how well M6620 works in treating patients with advanced solid tumors. M6620 is a drug designed to block the ATR enzyme. ATR repairs damaged DNA. In cancer, ATR may protect the cancer cells by helping them repair damage. Blocking ATR may keep cancers from repairing their damaged DNA; slowing the growth of, or killing cancer cells. The study will be recruiting people with different types of cancer, including people with advanced solid tumors and a BRCA1, BRCA2 or ATM mutation. UPDATE: THIS STUDY IS NO LONGER ENROLLING PATIENTS.

Clinicaltrials.gov identifier: NCT03718091

A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

This study will validate and evaluate the performance of the IMMray PanCan-d test for pancreatic cancer diagnosis in comparison to standard of care imaging currently used in pancreatic cancer disease surveillance by the research sites’ institutions. ENROLLMENT HAS CLOSED FOR THIS STUDY!

Clinicaltrials.gov identifier: NCT03693378

INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer (INTERVAL)

This study will determine if high intensity aerobic and resistance training (with supervised exercise) plus psychosocial support increases overall survival compared to psychosocial support alone (with self-directed exercise) in patients with metastatic castrate-resistant prostate cancer. NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT02730338

Patient-Driven Clinical Classification of Genetic VUS (Variants of Uncertain Significance)

NOTE: This study is no longer enrolling.

Making Genetic Testing Accessible (MAGENTA)

The goal of this research study is to test the effects of online genetic education alone or in combination with telephone genetic counseling in order to compare the two methods and the stress a person feels about their risk of cancer. NOTE: This study has closed for enrollment.

Clinicaltrials.gov identifier: NCT02993068

IMProving Executive function Study

Dr. C. Neill Epperson and her research team at the Penn Center for Women's Behavioral Wellness are studying the effects of a stimulant medication called Vyvanse® on memory and attention in women who had surgery to remove their ovaries to lower their risk for ovarian cancer (risk-reducing salpingo-oophorectomy or RRSO). NOTE: The study offers travel reimbursements and hotel accommodations for those eligible to participate.

NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT03187353

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer. (OlympiA)

The OlympiA trial is the first major study to test a targeted therapy for people with BRCA mutation-associated breast cancer in the adjuvant setting (after surgery) for people with earlier-stage (stage 2 or stage 3) cancers. The OlympiA trial has now completed enrollment. Interim results from OlympiA were presented at the 2021 ASCO Annual Symposium.

Clinicaltrials.gov identifier: NCT02032823

Dose-Response of Aerobic Training in Post-Menopausal Women at High-Risk for Development of Breast Cancer

In this study, researchers wanted to determine the optimal amount of exercise needed to change certain factors associated with breast cancer risk for post-menopausal, high-risk women.

NOTE: THIS STUDY ENROLLMENT HAS CLOSED

Clinicaltrials.gov identifier: NCT02494869

Prospective Registry Of MultiPlex Testing (PROMPT)

PROMPT is an online research registry for people who have had genetic panel testing (also known as multiplex testing) — a newer form of genetic testing that looks for mutations in several different genes at once. All genes on the panels have been linked to an increased risk of cancer, but some risks are better known than others.

The goal of the PROMPT Registry is to follow people with mutations or variants in genes on these panels, so that patients, physicians, and researchers can more clearly understand these lesser-known risks.

Clinicaltrials.gov identifier: NCT02665195

Serum Folate in Patients Treated with Olaparib

This is a study looking at folate deficiency (lack of folic acid in the blood) in patients who take the drug olaparib (Lynparza) to treat their advanced ovarian or breast cancer. The main goal of this study is to measure how often and when folate deficiency is most likely to occur; and to learn more about whether giving folic acid supplements (vitamins) will help delay or avoid deficiency in these patients. Folate deficiency can cause side effects and lead to reduction or stopping of treatment with olaparib. NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT04024254

Talazoparib Beyond BRCA (TBB) Trial

The goal of the study is to evaluate the anti-cancer activity of Talazoparib (a type of treatment known as a PARP inhibitor) in patients with advanced breast cancer with specific genetic mutations based on a blood, saliva, or tumor test. See the clinicaltrials.gov listing for additional information. NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT02401347

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

ARIEL4 is a treatment study for women with relapsed, high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who have a BRCA1 or BRCA2 mutation. ARIEL4 is designed to evaluate rucaparib against standard of care chemotherapy in women who have had at least two prior chemotherapy regimens. UPDATE: THIS STUDY IS NO LONGER ENROLLING PATIENTS

Clinicaltrials.gov identifier: NCT02855944

Additional Results on Clinicaltrials.gov
1000 results

Clinical Trial	Official Title
NCT05930483	Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
NCT05176483	Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
NCT04945642	High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
NCT07220135	Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
NCT04658303	Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
NCT05761561	Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
NCT07293585	Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment
NCT05720338	Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
NCT05746325	Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer
NCT05929768	Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
NCT05128890	Evaluation of Resection Techniques for Pancreatic Tumors
NCT05758688	PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
NCT06325046	Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
NCT04989946	Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
NCT07214610	Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
NCT07524322	Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
NCT06907446	Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies
NCT07184970	PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
NCT06303505	FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
NCT07470853	A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
NCT07109817	Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer
NCT06904313	Ultralow Dose PET Imaging for PSMA Expression
NCT00001823	Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT07623941	CUIMC Focal Therapy Registry
NCT06026657	Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
NCT06731894	Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
NCT06844383	A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate
NCT04510129	A Multicenter Cancer Biospecimen Collection Study
NCT03824145	Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
NCT01950572	Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
NCT06650579	REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
NCT07409272	A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
NCT07396766	Dissemination of BREASTChoice AIM1-B
NCT05130801	A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
NCT06511141	Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT03539822	Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
NCT07491445	Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT06574022	Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
NCT01530373	Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
NCT06400472	A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
NCT07114601	A Study of LY4257496 in Participants With Cancer (OMNIRAY)
NCT07630402	Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer
NCT07121972	Mirai-MRI: Validation of AI Models for Breast Cancer Risk
NCT07340541	Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
NCT06568562	XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT05985954	Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
NCT05867251	Study of AVZO-021 in Patients With Advanced Solid Tumors
NCT06179160	A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
NCT06855654	Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
NCT07017673	Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
NCT04167969	The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
NCT05790213	Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
NCT05825482	Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout®
NCT07190469	PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
NCT05136196	BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
NCT07244341	A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT06507930	The COMPASSION Study
NCT06526299	Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
NCT06225011	Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer
NCT05765500	RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
NCT02584244	Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
NCT04722692	Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
NCT07050771	Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
NCT05132504	Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
NCT06581406	A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
NCT07024784	A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
NCT07141121	Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen
NCT06689956	Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
NCT06892275	The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
NCT05035836	A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
NCT06463028	Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
NCT06801236	Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07102381	A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
NCT02328677	ColoCare Study - Colorectal Cancer Cohort
NCT07184957	Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
NCT03937453	A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
NCT06534125	Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer
NCT05447923	Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
NCT05877859	Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
NCT04997096	Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
NCT05803382	Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
NCT07276880	Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
NCT07324096	A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer
NCT05384535	Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
NCT04915508	Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy
NCT06340568	A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
NCT06925724	A Study of Ivonescimab in People With Endometrial and Cervical Cancers
NCT06127979	A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
NCT06915025	Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
NCT04333706	A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
NCT03675893	RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
NCT07581184	A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT05787834	Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
NCT07206121	Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
NCT04370587	A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
NCT04895709	A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT06400563	MRg-NIRS Imaging System Breast Cancer Trial
NCT03340506	Dabrafenib and/or Trametinib Rollover Study
NCT06418204	Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT05038332	Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
NCT06318273	A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07025369	Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
NCT06954831	Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
NCT07310446	Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
NCT05804370	Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
NCT07303894	A Study of Isoquercetin in People With Ovarian Cancer
NCT06833866	Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer
NCT04981119	Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
NCT06710756	Lead-212 PSV359 Therapy for Patients With Solid Tumors
NCT05435495	Mechanisms of Resistance to PSMA Radioligand Therapy
NCT06827236	A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
NCT00898131	Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer
NCT06831136	Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
NCT07148245	Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
NCT07237100	Mirdametinib in Patients With Advanced NF1-mutant Melanoma
NCT07287995	A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
NCT06746012	Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
NCT05627960	First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
NCT06123988	Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
NCT05751941	Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer
NCT06200259	Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
NCT00823654	Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
NCT06518746	Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
NCT05150691	A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
NCT05784688	Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
NCT04802759	A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
NCT05932862	A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
NCT06330064	A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
NCT03784924	EDRN Prostate MRI Biomarker Study
NCT05155046	18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
NCT06896474	SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
NCT06635980	Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
NCT06349590	Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
NCT05524935	Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
NCT06579417	ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
NCT06361940	Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
NCT05356117	Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
NCT02706561	Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
NCT06172283	Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
NCT05896839	Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
NCT05595499	Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
NCT05064098	Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients
NCT04995198	PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
NCT04114136	Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
NCT06517212	Tirzepatide Weight Loss for MRD+ Early Breast Cancer
NCT06518057	Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
NCT07622901	Fasting InTervention for Endometrial Cancer
NCT06545045	Cognitive Rehabilitation Following Breast Cancer Treatment
NCT06238921	Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
NCT04516447	A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
NCT05256225	Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
NCT05313191	Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
NCT06617858	Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
NCT05325632	Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
NCT03785288	Vaginal Cuff Brachytherapy Fractionation Study
NCT07181161	Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
NCT03025256	Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
NCT06795529	Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
NCT05704283	3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
NCT05852041	rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
NCT06966388	Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
NCT04221542	Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07005154	A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT05417594	Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
NCT07073794	Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer
NCT06524895	Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery
NCT07148128	Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
NCT06710067	Urine Metabolites in the Diagnosis of Disease
NCT06111781	The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
NCT05595577	Improving Exercise Capacity With a Tailored Physical Activity Intervention
NCT05899361	A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
NCT07166042	Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies
NCT05373823	MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
NCT06665945	The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
NCT06756932	BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
NCT05941507	A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
NCT06856499	Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
NCT05559164	Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
NCT07389967	Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
NCT00969111	Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
NCT06792695	A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
NCT06671730	Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer
NCT06169371	Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
NCT04698564	Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
NCT04563507	Combined Immunotherapies in Metastatic ER+ Breast Cancer
NCT06910761	Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
NCT05900895	Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
NCT06941857	NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
NCT06165419	Definitive Radiation for High-Risk Spine Metastases
NCT00949819	Active Surveillance for Cancer of the Prostate (ASCaP)
NCT05824975	A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
NCT00034216	Collection of Blood From Patients With Cancer
NCT00001276	Diagnosing and Treating Low Blood Sugar Levels
NCT06205316	SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
NCT04991948	Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
NCT07040514	24GUT540 : Meeting of Breast Cancer Patients and Pathologists
NCT04775355	Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer
NCT06425926	Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
NCT05428735	The DRAGON 2 Trial
NCT07259304	Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
NCT06961955	5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
NCT06756035	CT-95 in Advanced Cancers Associated With Mesothelin Expression
NCT06876714	ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
NCT06492616	A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT01042379	I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
NCT06789653	A Novel Approach Utilizing Organ Specific Age Proteomics
NCT05921253	Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
NCT06629779	A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
NCT06141031	Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
NCT07515846	Breast Cancer Screening Decision Aid
NCT06984562	Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
NCT06986083	A Study of Changes to Prostate Procedures
NCT06447662	A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
NCT04075305	The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT04947254	Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
NCT01102556	PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
NCT02064673	Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
NCT05785741	A Study of DB-1310 in Advanced/Metastatic Solid Tumors
NCT06068257	Tumor-Derived FGF19
NCT07218809	AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
NCT04598009	Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
NCT05219695	Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)
NCT07258407	A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer
NCT06103864	A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
NCT03804944	Converting HR+ Breast Cancer Into an Individualized Vaccine
NCT04918186	Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
NCT06327490	A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer
NCT07546500	A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
NCT06880055	Shield Post-Approval Study Protocol
NCT07259317	Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
NCT06922591	Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
NCT02526368	Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
NCT07118176	Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
NCT03968406	Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
NCT06743126	SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
NCT07076485	Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer
NCT06826768	A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
NCT06504914	Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors
NCT05053555	High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
NCT06682650	Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
NCT01205815	Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
NCT05505643	Cryoablation vs Lumpectomy in T1 Breast Cancers
NCT07203378	Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
NCT05376878	An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
NCT07160335	A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
NCT07628634	Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
NCT05508906	Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
NCT07201376	Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically
NCT05406232	Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
NCT05088798	Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism
NCT07548164	Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NCT06321484	Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
NCT07211178	Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
NCT05667532	The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts
NCT06141993	ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
NCT05287451	Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
NCT06654037	Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
NCT04722341	Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
NCT05633654	Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NCT05848141	Rowing Following Breast Cancer Chemotherapy
NCT06037954	A Study of Mental Health Care in People With Cancer
NCT06067503	Biomarkers to Detect Endocrine Therapy Resistance
NCT04294927	TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT02302742	Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
NCT07322094	CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
NCT07618273	Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial
NCT07402473	Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer
NCT05556473	F-Tryptophan PET/CT in Human Cancers
NCT01365169	Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
NCT03451383	Older Breast Cancer Patients: Risk for Cognitive Decline
NCT07127003	ILR to Prevent BRCL_MCC 23608
NCT06705803	Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
NCT07574671	Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer
NCT06785636	A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
NCT03460977	A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT05557877	Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
NCT06318507	The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
NCT06845319	NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
NCT06247995	A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
NCT07032545	Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
NCT06674811	Biomarkers of Resiliency In Childhood Cancer Surgery
NCT01834001	Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
NCT06411795	Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
NCT03805919	Men at High Genetic Risk for Prostate Cancer
NCT06395519	A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
NCT06362369	A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
NCT06963905	Saci Nivo Rela for TNBC
NCT04878094	A Study of Intra-operative Imaging in Women With Ovarian Cancer
NCT03396341	Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
NCT04291105	Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
NCT07126158	Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
NCT06638307	A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
NCT04844528	Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
NCT04084730	Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
NCT03723928	S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NCT06940739	A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
NCT06961357	Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
NCT07114939	FTT PET/CT in Pancreatic Neuroendocrine Tumors
NCT06128551	Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
NCT06773897	Rutgers University Study of the Genetics of Breast Cancer.
NCT05946824	This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
NCT05134779	De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
NCT05915442	Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
NCT03694756	TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
NCT05238922	Study of INCB123667 in Subjects With Advanced Solid Tumors
NCT06549465	Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
NCT03408353	Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
NCT07597837	Oncoplastic Surgery Outcomes Database
NCT05570253	A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
NCT06802172	Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
NCT06365853	A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
NCT06336902	Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
NCT07554560	Nutrition Intervention for Pancreatic Cancer
NCT04890613	Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
NCT07158164	DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
NCT02886247	Pancreatic Cancer Registry: For Any Person With a Personal or Family History
NCT07223047	A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
NCT06998940	Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
NCT05242744	FTT PET/CT in Metastatic Prostate Cancer
NCT05042687	Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
NCT06437574	Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
NCT05014399	Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
NCT02021604	Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
NCT07075731	Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
NCT05129605	Prostate Cancer Genetic Risk Evaluation and Screening Study
NCT07313241	Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)
NCT06678269	A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
NCT04406831	The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
NCT05253651	A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT02621021	A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
NCT02960022	A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
NCT05155033	Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
NCT04543071	Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
NCT05130606	CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
NCT04115163	Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
NCT04606914	Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT02012699	Integrated Cancer Repository for Cancer Research
NCT04003038	Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
NCT06450106	Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
NCT04389632	A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT07209449	A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
NCT04700332	PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
NCT05524584	Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
NCT04052048	Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
NCT06582615	Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
NCT06867484	Breast Re-irradiation After Second Ipsilateral Lumpectomy
NCT06890338	A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
NCT03050268	Familial Investigations of Childhood Cancer Predisposition
NCT06150417	MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
NCT05323409	Improving Comprehensive Care of Cancer Patients
NCT06580314	Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
NCT06562192	Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT05327608	Neoadjuvant Breast Cancer Time Restricted Eating
NCT03351348	Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
NCT06932757	Adjuvant Quisinostat in High-Risk Uveal Melanoma
NCT02332668	A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
NCT06066138	A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
NCT07128355	Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
NCT06926868	A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
NCT05803941	Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
NCT06385925	A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
NCT06096688	Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
NCT07407959	Screening and Staging of Benign vs Malignant Pelvic Abnormalities
NCT07214779	Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT04763980	Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
NCT04704505	Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT06638294	Study in Patients With Breast Cancer Leptomeningeal Metastasis
NCT05654246	Susan G. Komen's ShareForCures
NCT06952803	A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
NCT05464082	Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
NCT04701476	TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
NCT06502691	[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
NCT06931340	Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
NCT07238023	Promoting Active Living Among People With Metastatic Breast Cancer
NCT04891068	BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
NCT07450859	A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07335796	A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
NCT05941520	Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT03567889	Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT06637306	Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
NCT06613100	Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
NCT02863172	Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes
NCT07223411	Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma
NCT04924075	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
NCT06533644	A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT05607004	(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
NCT07089940	OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
NCT06682390	Role of Race in Nutritional Approach in Men on ADT
NCT05586360	T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
NCT06858449	Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
NCT06548789	Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
NCT05691010	A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
NCT05280314	Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
NCT04258280	Improving Genetic Counseling for BRCA+ Mothers
NCT07186296	EXoPERT EMERALD Clinical Study
NCT05919108	Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
NCT06127797	Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue
NCT06585410	Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
NCT04636710	Refining Local-Regional Therapy for IBC
NCT04796220	Focused Ultrasound and Gemcitabine in Breast Cancer
NCT05655494	A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
NCT06586957	A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NCT06925737	A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT00756665	Prostate Active Surveillance Study
NCT05736367	Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
NCT05462496	Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
NCT06106477	Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
NCT04291755	Development and Analysis of a Stool Bank for Cancer Patients
NCT03608631	iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
NCT05968157	MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick
NCT07058012	A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
NCT07252232	Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
NCT06355336	Real World Prostate Cancer Registry
NCT07189195	TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
NCT06885034	A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
NCT05935384	SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
NCT05673200	Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer
NCT07121244	A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer
NCT06481592	A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
NCT07368998	To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
NCT06790693	A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
NCT07190300	TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
NCT07285044	The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
NCT04903119	Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
NCT05334732	Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
NCT05206331	CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
NCT06022029	A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
NCT06454383	Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
NCT06997029	A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
NCT02610439	Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
NCT06592924	Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
NCT07219303	Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
NCT04553770	Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
NCT06430541	Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
NCT01915225	Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
NCT06414590	Neoadjuvant Tebentafusp for Uveal Melanoma
NCT03796559	Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
NCT07213791	A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
NCT06962059	Healthy Volunteers Study
NCT06469281	A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
NCT05535192	TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
NCT06624644	A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
NCT06966453	A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
NCT06600698	Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
NCT06607458	Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
NCT06745804	Study of 68Ga-R10602
NCT03678025	Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
NCT05193149	Inspiratory Muscle Training in Obese Breast Cancer Survivors
NCT05743049	Collection of Circulating Biomarkers in Pancreatic Cancer
NCT06265285	Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
NCT07257484	Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
NCT03093909	Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
NCT06270706	A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
NCT06586047	Breast Cancer PSMA PET
NCT06878547	VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
NCT06997497	A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
NCT05913713	HIIT Following Breast Cancer Chemotherapy
NCT04475640	Cancer Genetic Testing in Ethnic Populations
NCT07393906	Colorectal Cancer Prevention Research Study: Eat Right, Screen Right
NCT05488548	Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
NCT05020574	Microbiome and Association With Implant Infections
NCT06522568	Testing a Mammography Decision Intervention in a Rural Setting
NCT06096623	The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment
NCT05676255	The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
NCT05386108	Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
NCT06297525	Study of STP938 in Advanced Solid Tumours
NCT07271017	Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
NCT06831838	A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
NCT05868226	PRE-I-SPY Phase I/Ib Oncology Platform Program
NCT07254091	Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer
NCT05013255	Pioglitazone Therapy Targeting Fatigue in Breast Cancer
NCT02250352	Core Biopsies for Establishing a Breast Tumor Tissue Repository
NCT04751435	Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
NCT07028853	This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT01000883	Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT05797831	Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
NCT01521741	Prospective Screening for Breast Cancer-related Lymphedema
NCT04318717	Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
NCT06441890	BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer
NCT00991094	Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
NCT06226129	Gadopiclenol in Contrast Enhanced MRI of the Prostate
NCT06075953	DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
NCT06120283	BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT03860883	Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
NCT06995924	Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
NCT04464759	A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
NCT07506876	Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
NCT06130280	A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
NCT06595160	Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
NCT05123482	A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
NCT07294703	Factors Associated With Breast Cancer Risks and Outcomes
NCT06444269	Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial
NCT04074720	Prospective Breast Cancer Biospecimen Collection
NCT07361562	A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
NCT05223803	TERPS Trial for de Novo Oligometastic Prostate Cancer
NCT05593497	A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
NCT05349227	Comprehensive Outcomes for After Cancer Health
NCT03808337	Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
NCT06612281	Evaluation of Gixam's Performance in a FIT Negative Population
NCT07173257	PROMs After Pancreatectomy
NCT05856981	Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
NCT04071236	Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy
NCT05894239	A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
NCT05887609	An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
NCT04115306	Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
NCT06350500	A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
NCT04458532	Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
NCT07237594	IL-17 Blockade to Decrease irAEs (REPLAY)
NCT03151629	International Registry for Men With Advanced Prostate Cancer (IRONMAN)
NCT06694181	Safe and Explainable AI
NCT06466434	Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma
NCT05950464	Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
NCT06062498	Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer
NCT05013216	Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
NCT06799065	First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
NCT06906341	Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
NCT06815354	Comprehensive Assessment of Cancer Theranostic Response
NCT01776905	In Vivo Real-time Detection of Circulating Melanoma Cells
NCT07283705	A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
NCT06705686	Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
NCT06253494	Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
NCT07193862	Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
NCT06100705	Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
NCT06185205	ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
NCT04812366	Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
NCT05231122	Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
NCT06750094	A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
NCT07142551	Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
NCT06712927	Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
NCT06492070	Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
NCT06646627	Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
NCT03190941	Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
NCT06004245	A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
NCT03701581	4-aminopyridine Treatment for Nerve Injury
NCT02843945	Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
NCT07227077	Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
NCT05291507	Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
NCT07206056	An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
NCT06272864	BostonGene and Exigent Genomic INsight Study
NCT05873192	Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
NCT06568692	A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
NCT07222436	Circulating Tumor DNA in High Risk Localized Prostate Cancer
NCT05225363	Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
NCT01034033	Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
NCT07636200	The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
NCT06795009	Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
NCT06439693	The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
NCT07142967	Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)
NCT07044336	Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
NCT06202066	Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
NCT06267729	Study of AZD0754 in Participants With Metastatic Prostate Cancer
NCT03954431	High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
NCT06538337	Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
NCT06465966	UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning
NCT06492122	Study With [225Ac]Ac-FL-020 in mCRPC Participants
NCT07197554	A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
NCT06695845	A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
NCT03941756	Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
NCT06833502	Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
NCT07173101	Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients
NCT07070232	A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
NCT04368702	CONFIRM: Magnetic Resonance Guided Radiation Therapy
NCT06706921	18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
NCT06401421	EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
NCT07527858	Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
NCT04678648	A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT06930755	Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
NCT05637216	Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
NCT05826743	Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy
NCT07455058	Water Vapor Ablation for Prostate Cancer: Long-Term Registry
NCT06271291	Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
NCT06974110	Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
NCT05797168	Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT06347068	Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
NCT07127874	A Study of PHN-012 in Patients With Advanced Solid Tumors
NCT05786924	Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
NCT06445062	Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
NCT06369246	PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.
NCT07549958	PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC)
NCT07321106	A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
NCT07115043	A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT05080946	Using Aspirin to Improve Immunological Features of Ovarian Tumors
NCT07082920	A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
NCT04055649	ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
NCT06887348	A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
NCT03659448	Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
NCT05142033	Avera Cancer Sequencing and Analytics Protocol (ASAP)
NCT05519449	Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
NCT03334708	A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT05698576	TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
NCT06263088	EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
NCT03096418	Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
NCT05568680	SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
NCT06492759	High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
NCT05692024	COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
NCT07044362	Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
NCT06515613	A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
NCT06617923	Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
NCT07408089	Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
NCT07137468	Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk
NCT03053193	MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
NCT06428721	The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
NCT05914987	Determining Individualized Cancer Therapy in Pancreatic Cancer
NCT06290193	Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
NCT07094204	A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
NCT05190978	Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction
NCT06500481	Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
NCT05295407	Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT06745895	Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
NCT07276386	Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma
NCT06073431	LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
NCT07281924	Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
NCT06461650	Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction
NCT03866382	Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
NCT04548817	Neurocutaneous Melanocytosis Registry
NCT07544589	A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
NCT05691491	Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
NCT01961713	Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy
NCT05056818	Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
NCT04683315	PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
NCT06726148	Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
NCT05417308	Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
NCT07300150	A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
NCT03729115	A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
NCT06751589	A Study of a Weight Loss Intervention in People With Endometrial Cancer
NCT06044025	A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy
NCT06730750	A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
NCT05799274	Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors
NCT06371768	Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
NCT04329065	Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
NCT04787744	Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
NCT07307664	Increasing Germline Genetic Testing for Patients With Cancer
NCT03492671	Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
NCT03823144	Intravital Microscopy in Human Solid Tumors
NCT04706663	Precision-Based Genomics in Prostate Cancer
NCT06161506	Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
NCT06014255	Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
NCT05391126	GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
NCT03448926	The PREDICT Registry:
NCT07042685	Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
NCT03536897	IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
NCT06173310	DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
NCT07337590	Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
NCT07645391	Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
NCT07264790	Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon
NCT06111313	The University of Miami Adapt (UAdapt) Trial
NCT06827613	A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
NCT05598879	Global Cardio Oncology Registry
NCT06736054	A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
NCT06807437	Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
NCT05607095	A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
NCT03769766	Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
NCT04886531	Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
NCT06281678	A Study of IBI363 in Subjects with Advanced Solid Malignancies
NCT07377526	Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer
NCT07070726	UNTOLD Ovarian Cancer Unmet Needs Survey
NCT07109726	A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
NCT06945315	SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
NCT07215988	Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
NCT03686124	ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
NCT06529523	Tislelizumab in People With Colorectal Cancer
NCT03819296	Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
NCT07463599	Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
NCT05636111	Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
NCT07125729	Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
NCT05890677	The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NCT07288359	Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
NCT06121180	Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
NCT06574880	STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
NCT06179303	Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
NCT06040970	Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
NCT04157127	Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
NCT06096870	Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
NCT05334069	Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT06178354	Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer
NCT05630794	Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
NCT05128825	A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT07503808	A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
NCT07559825	Early-Onset Colorectal Cancer Patients Too Young for Screening
NCT04188535	Serial MRI Scans During Radiation Therapy
NCT06542835	Community Partnership for Telehealth Solutions to Convey Information and Enhance Care
NCT06959550	Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
NCT06785441	Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
NCT04787042	Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
NCT06751329	A Study of DM002 in Patients With Advanced Solid Tumors
NCT07280312	Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
NCT06465069	A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
NCT05269381	Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
NCT05627219	Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
NCT05564377	Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
NCT06591819	Hypofractionated WPPT With HDR Boost
NCT03556228	VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
NCT03933670	Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
NCT04550845	Understanding of Genetics by Men at Risk for Prostate Cancer
NCT06728072	Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
NCT07140172	Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT06599619	Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
NCT06158139	Autologous CAR-T Cells Targeting B7-H3 in PDAC
NCT07354919	Axelopran for Advanced Cancer in Patients Receiving Opioids
NCT07011654	Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
NCT06666439	Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
NCT06457919	A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
NCT06763432	Positive Fit to Colonoscopy: Closing the Gap
NCT07386444	Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
NCT04693377	Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
NCT05043012	Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
NCT07228832	Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
NCT06358430	Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)
NCT05472792	Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
NCT04363164	Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
NCT05001477	Customized TULSA-PRO Ablation Registry
NCT04994067	Intra-Operative Radiation Registry
NCT06697301	Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
NCT06063928	Confronting Cancer as a Community
NCT04389281	X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
NCT06657144	A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
NCT07361614	Pilot Testing of a Colorectal Cancer Education Program
NCT06297265	Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
NCT07140900	Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
NCT07229443	CoGENES Randomized Controlled Trial (RCT)
NCT06917313	FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
NCT05559879	Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
NCT07224750	A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
NCT05974150	Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
NCT02749474	Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
NCT05958082	Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer
NCT07544680	Endometrial Cancer Vaginal Fluid Specimen Collection Study
NCT02361320	Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
NCT04605913	Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
NCT07254910	Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
NCT06400550	Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT07505797	ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
NCT05764720	Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
NCT05732623	Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
NCT07517198	Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
NCT07306559	A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
NCT06451497	This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
NCT06995898	The Vanguard Study: Testing a New Way to Screen for Cancer
NCT07100106	A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
NCT05438563	MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
NCT06293898	Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
NCT02620852	Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
NCT07137416	Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
NCT04354064	Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
NCT07320664	Breast Cancer Study Tracking Risk Awareness of Alcohol Consumption and Improving Knowledge in Young Adult Women
NCT06744465	NearWave Optical Molecular Monitoring
NCT06072807	Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
NCT05428007	Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
NCT06938581	ERAS Protocols in Breast Conserving Surgery
NCT06065371	Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
NCT05922930	Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
NCT07483307	A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
NCT06675357	Using FAPI PET/MRI to Evaluate Prostate Cancer
NCT06954337	MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
NCT06413680	A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
NCT06682988	A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
NCT06218303	Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
NCT07172282	INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
NCT06826924	7-Days Water-Only Fasting Trial in Prostate Cancer
NCT06672497	Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients
NCT05267626	Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
NCT04588025	Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response
NCT06733350	Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
NCT06783179	Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement
NCT05369546	Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis
NCT07319871	A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
NCT07207564	Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
NCT05998135	Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
NCT05923684	NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
NCT06710548	REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
NCT05036226	COAST Therapy in Advanced Solid Tumors and Prostate Cancer
NCT07049276	The Multicentre Selective Lymphadenectomy Trial - 3
NCT04765150	Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
NCT06332755	Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
NCT05766891	Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
NCT06409052	Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
NCT05624918	A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
NCT07611110	AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07023627	A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT04779554	Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
NCT07310420	A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer
NCT05413850	Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
NCT05561842	Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
NCT06112613	Mobile Health for Adherence in Breast Cancer Patients
NCT06234423	A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
NCT05687123	Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
NCT04134780	Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
NCT02775461	Pancreas Registry and High Risk Registry
NCT07224841	Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
NCT07417488	GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
NCT04038502	Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
NCT05470920	Genetic Testing Decision Aid
NCT05298605	Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
NCT06966024	Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
NCT07285694	AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)
NCT05770531	Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
NCT06334354	A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
NCT05422794	Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
NCT03977233	Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
NCT05967533	The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors
NCT06145633	Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
NCT06971744	Autophagy Maintenance (AUTOMAIN)
NCT03354416	Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
NCT03054584	Genetic Basis of Melanocytic Nevi
NCT06249048	Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
NCT02290834	Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
NCT06253871	A Phase 1/1b Study of IAM1363 in HER2 Cancers
NCT04472338	Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
NCT03382158	International PPB/DICER1 Registry
NCT01772771	Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
NCT05877599	A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
NCT07227038	Living Well With Advanced Breast Cancer
NCT04222413	Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
NCT06651580	Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
NCT07025785	Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
NCT05610735	Combination Therapy for Recurrent Ovarian Cancer
NCT04119024	Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT02896335	Palbociclib and Pembrolizumab In Central Nervous System Metastases
NCT07220720	POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
NCT07137871	Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy
NCT06006806	Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy
NCT03906253	Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
NCT07018869	Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
NCT04562129	IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
NCT05490472	JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
NCT03863457	[18F] F-GLN by PET/CT in Breast Cancer
NCT06824467	A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
NCT06147037	A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
NCT06972628	Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617
NCT07210086	Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)
NCT06302595	MRI Guided Prostate Biopsy
NCT05455619	Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
NCT01788839	Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
NCT03492151	Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
NCT06130995	Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
NCT07006727	Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
NCT06879041	A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07001241	Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
NCT07069556	ColoSense Post-Approval Study
NCT06864754	WashU DIEP Flap Video and Patient Understanding Improvement
NCT06085664	A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
NCT07213804	A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
NCT05501704	ETHAN - ET for Male BC
NCT06129747	Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
NCT06168487	Telmisartan in Prostate Cancer
NCT06218914	Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
NCT06730347	A Study of Lorigerlimab in Participants With Advanced Solid Tumors
NCT05141149	First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer
NCT06195306	Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
NCT06974604	Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
NCT04985032	Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
NCT06617481	PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
NCT05417867	Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer
NCT07227636	A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
NCT07016399	Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
NCT05950945	Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
NCT06153836	Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction
NCT05647564	PET/CT Characterization of Treatment Resistance
NCT07222800	Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
NCT00843375	Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT05524428	Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
NCT04711824	Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
NCT06524973	Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers
NCT07066189	Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
NCT06340620	EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
NCT07336446	A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
NCT01766297	Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
NCT07224425	A Study of BI 3810944 in Patients With Advanced Cancer
NCT06557733	An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
NCT06993844	Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
NCT05218044	Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
NCT07125209	Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
NCT02997709	Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
NCT06964009	DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
NCT06842498	A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT07218432	A Study of the TheraBionic P1 Device in Breast Cancer
NCT06566716	A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
NCT06274047	PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
NCT04847063	Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
NCT05413421	Study of ORIC-944 in Patients With Metastatic Prostate Cancer
NCT07202247	Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
NCT05684367	Exercise to ReGain Stamina and Energy (The EXERGISE Study)
NCT05780814	The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
NCT06759701	Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
NCT05355701	A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
NCT06056830	Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
NCT05095207	Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
NCT03934905	Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
NCT04275557	Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
NCT05877430	Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
NCT03412877	Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
NCT06008275	Neratinib in Combination With Ruxolitinib in Patients With mTNBC
NCT06757634	Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06875128	Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
NCT07319195	Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
NCT06190899	Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
NCT07535541	A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
NCT07459673	HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
NCT05011383	High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
NCT04494945	Identifying and Caring for Individuals With Inherited Cancer Syndrome
NCT05975593	MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
NCT04692675	Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT06998407	ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
NCT05297734	Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
NCT06982521	Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
NCT06434064	Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
NCT02610426	Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
NCT04030507	Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
NCT06831071	Evaluation of Hypoxia in Primary Melanoma
NCT06039371	Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
NCT06245889	PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
NCT07146568	Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
NCT06922318	The COSMYC Trial (COmbined Suppression of MYC)
NCT03257033	Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
NCT06610825	Castrate Resistant Prostate Cancer Enhertu Therapy
NCT04265872	Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
NCT05588453	Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
NCT01492972	Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
NCT04774419	Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery
NCT06242470	A Study of MGC026 in Participants With Advanced Solid Tumors
NCT04239573	Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
NCT06906562	A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
NCT03832361	Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
NCT04668872	Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
NCT06593431	Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
NCT06888102	A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
NCT06264180	VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
NCT07522073	A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
NCT06117241	Reducing Metabolic Dysregulation in Dyads
NCT04550494	Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
NCT07166094	Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
NCT06525766	Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
NCT07162194	MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
NCT05469269	Cleveland African American Prostate Cancer Project
NCT06686394	Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
NCT05440929	Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
NCT06223659	EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
NCT07164027	Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
NCT07427394	Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer
NCT04741997	Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
NCT04657068	A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT05625659	Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NCT07014618	Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
NCT06639074	Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
NCT05549297	Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
NCT07122713	Definitive Radiation Therapy for Inoperable Breast Cancer
NCT06110793	A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
NCT00899626	Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
NCT07229313	A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
NCT06383026	Individuals on Hormone Therapy Breast Cancer Screening Pilot
NCT05125016	A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
NCT04517838	Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
NCT05946213	Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
NCT06749210	DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
NCT07433660	WellSpan-THRIVE Cancer QOL Study
NCT02610413	Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
NCT06946225	ACTengine® IMA203 Combined With mRNA-4203
NCT05259410	Time Restricted Eating During Chemotherapy for Breast Cancer
NCT06804785	Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)
NCT06112990	Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
NCT06409390	Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
NCT06136650	A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
NCT06001268	Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
NCT06136624	Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
NCT06374459	Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
NCT07278986	CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
NCT04778449	Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
NCT06065748	A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
NCT07167446	Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
NCT05518903	Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
NCT04048278	Lidocaine Infusion in Pancreatic Cancer
NCT07529717	First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
NCT06594991	A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
NCT07219147	177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT05837455	NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
NCT03454035	Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
NCT04074135	Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
NCT04923178	A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
NCT06797635	Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
NCT06252649	Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
NCT05086250	Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
NCT05562791	A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
NCT06036810	Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
NCT04771520	Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
NCT05710380	MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
NCT06690775	CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT07288112	DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
NCT04674267	Resilience and Equity in Aging, Cancer, and Health (REACH)
NCT05800665	A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
NCT05660083	Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
NCT00539162	Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
NCT01503190	The Immune System's Response to Young Women's Breast Cancer
NCT04808427	Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
NCT05629494	Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
NCT06862856	Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
NCT06075524	Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
NCT04886986	Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
NCT07225270	Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
NCT07223424	Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
NCT07225946	A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Search Results: (19 results)

Safety and Efficacy of Olaparib Alone Or in Combination with Medication Targeting DNA Damaging Repair for Metastatic Triple Negative Breast Cancer

Olive Oil for High Risk Breast Cancer Prevention

Auricular Point Acupressure to Self-Manage Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)

Study of Safety and Effectiveness of Motiva® Breast Implants

The Women Choosing Surgical Prevention (WISP) Trial

A Study to Evaluate Rucaparib in Patients with Solid Tumors and with Deleterious Mutations in HRR Genes (LODESTAR)

A Non-Randomized Phase II Research Study of M6620 (VX-970) in Selected Solid Tumors to Inhibit the ATR Enzyme.

A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer (INTERVAL)

Patient-Driven Clinical Classification of Genetic VUS (Variants of Uncertain Significance)

Making Genetic Testing Accessible (MAGENTA)

IMProving Executive function Study

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer. (OlympiA)

Dose-Response of Aerobic Training in Post-Menopausal Women at High-Risk for Development of Breast Cancer

Prospective Registry Of MultiPlex Testing (PROMPT)

Serum Folate in Patients Treated with Olaparib

Talazoparib Beyond BRCA (TBB) Trial

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Additional Results on Clinicaltrials.gov
1000 results

Sponsored By

Knowledge Can Save Lives

Search Results: (19 results)

Additional Results on Clinicaltrials.gov 1000 results

Sponsored By

Knowledge Can Save Lives

Additional Results on Clinicaltrials.gov
1000 results